The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy of belinostat in advanced hepatocellular carcinoma (HCC): Phase I and II multicentered study of the Mayo Phase 2 Consortium (P2C) and the Cancer Therapeutics Research Group (CTRG).
Stephen Lam Chan
No relevant relationships to disclose
Hyun Cheol Chung
No relevant relationships to disclose
Ling-Zhi Wang
No relevant relationships to disclose
Robert S. C. Lim
No relevant relationships to disclose
Joel Picus
No relevant relationships to disclose
Michael J. Boyer
No relevant relationships to disclose
Charles Erlichman
No relevant relationships to disclose
Anthony T. C. Chan
No relevant relationships to disclose
Boon C. Goh
No relevant relationships to disclose
Winnie Yeo
No relevant relationships to disclose